4-Aminopyridine prevents the conformational changes associated with P/C-type inactivation in Shaker channels

Journal of Pharmacology and Experimental Therapeutics

Volumn 320, Issue 1, 2007, Pages 162-172

  Claydon, Thomas W ^a   Vaid, Moni ^a   Rezazadeh, Saman ^a   Kehl, Steven J ^a   Fedida, David ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPYRIDINE; AMINO ACID; CYSTEINE; MALEIMIDE DERIVATIVE; SHAKER POTASSIUM CHANNEL; TETRAMETHYLRHODAMINE 5 MALEIMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG BINDING; DRUG INHIBITION; DRUG MECHANISM; FLUOROMETRY; NONHUMAN; PRIORITY JOURNAL; REPOLARIZATION; VOLTAGE CLAMP;

4-AMINOPYRIDINE; ANIMALS; FEMALE; FLUORESCENCE; RHODAMINES; SHAKER SUPERFAMILY OF POTASSIUM CHANNELS; XENOPUS LAEVIS;

EID: 33845892184     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.110411     Document Type: Article

References (39)

1. Armstrong CM and Loboda A (2001) A model for 4-aminopyridine action on K channels: similarities to tetraethylammonium ion action. Biophys J 81:895-904.
2. Bever CT Jr, Anderson PA, Leslie J, Panitch HS, Dhib-Jalbut S, Khan OA, Milo R, Hebel JR, Conway KL, Katz E, et al. (1996) Treatment with oral 3,4-diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial. Neurology 47:1457-1462.
3. Bezanilla F (2002) Voltage sensor movements. J Gen Physiol 120:465-473.
4. Bouchard RA and Fedida D (1995) Closed and open state binding of 4-aminopyridine to the cloned human potassium channel Kv1.5. J Pharmacol Exp Ther 275:864-876.
5. Castle NA, Fadous SR, Logothetis DE, and Wang GK (1994) 4-Aminopyridine binding and slow inactivation are mutually exclusive in rat Kv1.1 and Shaker potassium channels. Mol Pharmacol 46:1175-1181.
6. + channel with fluorescence. Neuron 19:1127-1140.
7. Choquet D and Korn H (1992) Mechanism of 4-aminopyridine action on voltage-gated potassium channels in lymphocytes. J Gen Physiol 99:217-240.
8. + channel Kv1.4 by acidosis: protonation of an extracellular histidine slows the recovery from N-type inactivation. J Physiol (Lond) 526:253-264.
9. + pores. Pflueg Arch Eur J Physiol 422:354-363.
10. + channels. J Gen Physiol 126:419-428.
11. + channel gating kinetics by deletions in the S3-S4 linker. Proc Natl Acad Sci USA 98:9617-9623.
12. + channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Mol Pharmacol 45:1227-1234.
13. + channels: effects of alterations in the carboxyl-terminal region. Neuron 7:547-556.
14. + current in rat melanotrophs. J Physiol (Lond) 431:515-528.
15. Kirsch GE and Drewe JA (1993) Gating-dependent mechanism of 4-aminopyridine block in two related potassium channels. J Gen Physiol 102:797-816.
16. Kirsch GE and Narahashi T (1983) Site of action and active form of aminopyridines in squid axon membranes. J Pharmacol Exp Ther 226:174-179.
17. Kirsch GE, Yeh JZ, and Oxford GS (1986) Modulation of aminopyridine block of potassium currents in squid axon. Biophys J 50:637-644.
18. Kurata HT and Fedida D (2006) A structural interpretation of voltage-gated potassium channel inactivation. Prog Biophys Mol Biol 92:185-208.
19. Loboda A and Armstrong CM (2001) Resolving the gating charge movement associated with late transitions in K channel activation. Biophys J 81:905-916.
20. + channel. J Gen Physiol 112:377-389.
21. + Channel's slow inactivation gate. J Gen Physiol 116:623-636.
22. Lopez-Barneo J, Hoshi T, Heinemann SH, and Aldrich RW (1993) Effects of external cations and mutations in the pore region on C-type inactivation of Shaker potassium channels. Receptors Channels 1:61-71.
23. Mannuzzu LM, Moronne MM, and Isacoff EY (1996) Direct physical measurement of conformational rearrangement underlying potassium channel gating. Science (Wash DC) 271:213-216.
24. + channels. Neuron 12:301-315.
25. + channels. J Gen Physiol 110:579-589.
26. Pathak M, Kurtz L, Tombola F, and Isacoff E (2005) The cooperative voltage sensor motion that gates a potassium channel. J Gen Physiol 125:57-69.
27. + channels. Neuron 11:353-358.
28. + channel recovery from slow inactivation. J Gen Physiol 128:203-217.
29. + channels. Biophys J 67:2316-2325.
30. + channels. J Gen Physiol 109:767-778.
31. Smith-Maxwell CJ, Ledwell JL, and Aldrich RW (1998a) Role of the S4 in cooperativity of voltage-dependent potassium channel activation. J Gen Physiol 111:399-420.
32. Smith-Maxwell CJ, Ledwell JL, and Aldrich RW (1998b) Uncharged S4 residues and cooperativity in voltage-dependent potassium channel activation. J Gen Physiol 111:421-439.
33. + currents in the "nonconducting" Shaker potassium channel mutant W434F. J Gen Physiol 112:85-93.
34. Thompson S (1982) Aminopyridine block of transient potassium current. J Gen Physiol 80:1-18.
35. Tseng GN, Jiang M, and Yao JA (1996) Reverse use dependence of Kv4.2 blockade by 4-aminopyridine. J Pharmacol Exp Ther 279:865-876.
36. Wolfe DL, Hayes KC, Hsieh JT, and Potter PJ (2001) Effects of 4-aminopyridine on motor evoked potentials in patients with spinal cord injury: a double-blinded, placebo-controlled crossover trial. J Neurotrauma 18:757-771.
37. Yang YS, Yan YY, and Sigworth FJ (1997) How does the W434F mutation block current in Shaker potassium channels. J Gen Physiol 109:779-789.
38. Yao J-A and Tseng G-N (1994) Modulation of 4-AP block of a mammalian A-type K channel clone by channel gating and membrane voltage. Biophys J 67:130-142.
39. Yellen G (1998) The moving parts of voltage-gated ion channels. Q Rev Biophys 31:239-295.